Elevance Health (ELV): Price and Financial Metrics
GET POWR RATINGS... FREE!
ELV Stock Price Chart Interactive Chart >
ELV Price/Volume Stats
|Current price||$489.08||52-week high||$549.52|
|Prev. close||$492.53||52-week low||$431.96|
|Day high||$496.68||Avg. volume||1,263,900|
|50-day MA||$501.31||Dividend yield||1.05%|
|200-day MA||$492.02||Market Cap||117.38B|
Elevance Health (ELV) Company Bio
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Most Popular Stories View All
ELV Latest News Stream
|Loading, please wait...|
ELV Latest Social Stream
View Full ELV Social Stream
Latest ELV News From Around the Web
Below are the latest news stories about ELEVANCE HEALTH INC that investors may wish to consider to help them evaluate ELV as an investment opportunity.
Image source: The Motley Fool. Elevance Health (NYSE: ELV)Q4 2022 Earnings CallJan 25, 2023, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth quarter earnings conference call.
INDIANAPOLIS, January 25, 2023--Elevance Health, Inc. (NYSE: ELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 (the "Debentures") will accrue contingent interest at a rate of 0.50% per annum of the average trading price of a Debenture for the ten consecutive trading days ended October 14, 2022. Contingent interest, which the Company has determined to be approximately $16.8123 per Note, will be payable on
Elevance Health's (ELV) fourth-quarter earnings gain on solid premiums from its Medicaid business. Management approves a quarterly dividend hike of 16%.
Elevance Health reported higher revenue but a smaller profit for the fourth quarter as premiums rose in tandem with medical costs. The health insurer and healthcare-services provider, formerly known as Anthem Inc., said Wednesday that total revenue increased 9.2% to $39.93 billion, topping analyst expectations of $39.77 billion, according to FactSet. Total premiums were up 9.4% thanks to higher rates and more Medicaid and Medicare Advantage plan members.
Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ELV Price Returns
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|